$0.00
+0.00 (+0.00%)
Market Cap
—
Shares Outstanding
—
Institutional Holders
4
Total Inst. Value
$5K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2024
Top 10 Institutional Holders(Q1 2024)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | $5K | 235,294 |
| 2 | UBS Group AG | $22 | 1,094 |
| 3 | BANK OF AMERICA CORP /DE/ | $12 | 582 |
| 4 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | $0 | 0 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold TCBWF?
As of Q1 2024, 4 institutional investors report holding TCBWF (TC BIOPHARM (HLDGS) WTS) in their 13F filings.
Which hedge fund owns the most TCBWF?
The largest institutional holder of TCBWF is Nantahala Capital Management, LLC with $5K in shares.
Are institutions buying or selling TCBWF?
This quarter, 4 institutions opened new positions in TCBWF and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.